SH3 domain binding glutamate-rich protein-like 2 (SH3BGRL2) is critical for EMT progression and metastasis in ccRCC, and SH3BGRL2 exerts tumor inhibition through the Hippo pathway (Yin et al., 2020). This evidence concerns the gene SH3BGRL2 and neoplasm.